Mercado europeo de contadores gamma para inmunoensayos, por tipo de producto ( automatizado , manual/semiautomatizado), pozo (pocillos múltiples, pozo único), aplicación ( radioinmunoensayos , ensayos de medicina nuclear, otros), condición de la enfermedad ( biomarcador de cáncer , enfermedades infecciosas, monitoreo terapéutico de fármacos , hormonas endocrinas, alergia, detección neonatal, marcadores cardíacos , enfermedades autoinmunes, otros), modo de compra (compra directa, compra de alquiler), usuario final (laboratorio, hospitales, institutos de investigación y académicos, empresas farmacéuticas y de biotecnología, bancos de sangre, otros), canal de distribución (licitación directa, distribuidores externos), país (Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Bélgica, Turquía, Austria, Noruega, Hungría, Lituania, Irlanda, Polonia, resto de Europa), tendencias de la industria y pronóstico hasta 2028.
Análisis y perspectivas del mercado: mercado europeo de contadores gamma para inmunoensayo
Se espera que el mercado europeo de contadores de gamma e inmunoensayos gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 5,0% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 25,51 millones para 2028. La creciente prevalencia de enfermedades crónicas y la creciente adopción de la medicina nuclear son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.
Un inmunoensayo es una prueba bioquímica que mide la presencia o concentración de una macromolécula o una molécula pequeña en una solución mediante el uso de un anticuerpo o un antígeno. La prueba bioquímica se lleva a cabo a través de un dispositivo conocido como "Contador Gamma". Un contador gamma es un instrumento para medir la radiación gamma emitida por un radionúclido. A diferencia de los medidores de sondeo, los contadores gamma están diseñados para medir pequeñas muestras de material radiactivo, normalmente con medición y movimiento automatizados de múltiples muestras. Se espera que el aumento de los gastos de investigación y desarrollo, el aumento del gasto sanitario y la mayor concienciación de los pacientes sobre el tratamiento de enfermedades crónicas proporcionen una oportunidad de crecimiento lucrativa para el mercado. Sin embargo, el alto coste de los contadores gamma y el riesgo de la radiación gamma son los factores que se espera que limiten el crecimiento del mercado en el período de previsión.
La demanda del mercado de contadores de rayos gamma para inmunoensayos ha aumentado tanto en los países desarrollados como en los países en desarrollo, y la razón detrás de esto es un aumento en el gasto mundial en atención médica. El mercado de contadores de rayos gamma para inmunoensayos está creciendo debido a una mayor aprobación de productos tecnológicos avanzados y un mayor apoyo gubernamental. El mercado crecerá en el período previsto con un aumento de las iniciativas estratégicas por parte de los actores del mercado.
El informe de mercado de contadores gamma de inmunoensayo proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de contadores gamma para inmunoensayo en Europa
El mercado de contadores gamma para inmunoensayos está segmentado en función del tipo de producto, la aplicación, la enfermedad, el modo de compra, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- En función del tipo de producto, el mercado europeo de contadores gamma de inmunoensayo se segmenta en automatizados, manuales/semiautomáticos. En 2021, se espera que el segmento automatizado domine el mercado debido a los plazos de entrega de fábrica reducidos y a la capacidad de ser más competitivos.
- En términos generales, el mercado europeo de contadores gamma para inmunoensayos se segmenta en multipocillos y de un solo pocillo. En 2021, se espera que el segmento de multipocillos domine el mercado debido a las mediciones precisas y la capacidad de producir niveles espectrales más altos en un corto período de tiempo.
- En función de la aplicación, el mercado europeo de contadores gamma para inmunoensayos se segmenta en radioinmunoensayos, ensayos de medicina nuclear y otros. En 2021, se espera que los radioinmunoensayos dominen el mercado debido a su alta especificidad y sensibilidad.
- En función de la condición de la enfermedad, el mercado europeo de contadores gamma de inmunoensayo se segmenta en biomarcadores de cáncer, enfermedades infecciosas, monitoreo de medicamentos terapéuticos, hormonas endocrinas, alergia, detección neonatal, marcadores cardíacos, enfermedades autoinmunes y otros. En 2021, se espera que el segmento de biomarcadores de cáncer domine el mercado debido al estudio de los mecanismos de la enfermedad y la buena caracterización.
- En función del modo de compra, el mercado europeo de contadores de rayos gamma para inmunoensayos se segmenta en compra directa y compra de alquiler. En 2021, se espera que el segmento de compra directa domine el mercado debido a la mejora de la eficacia interna y la innovación.
- En función del usuario final, el mercado europeo de contadores gamma para inmunoensayos se segmenta en laboratorios, hospitales, institutos de investigación y académicos, empresas farmacéuticas y biotecnológicas, bancos de sangre, entre otros. En 2021, se espera que el segmento de laboratorio domine el mercado debido a la repetibilidad y la objetividad junto con el monitoreo en tiempo real.
- En función del canal de distribución, el mercado europeo de contadores de rayos gamma para inmunoensayos se segmenta en ventas directas y distribuidores externos. En 2021, se espera que el segmento de licitación directa domine el mercado debido a la reanudación de la contratación, el ahorro de costos y el talento independiente.
Análisis a nivel de país del mercado de contadores gamma de inmunoensayo
Se analiza el mercado de contadores gamma de inmunoensayo y se proporciona información sobre el tamaño del mercado en función del tipo de producto, pozo, aplicación, condición de la enfermedad, modo de compra, usuario final y canal de distribución.
Los países cubiertos en el informe del mercado de contadores gamma de inmunoensayo son Francia, Reino Unido, Italia, Alemania, España, Países Bajos, Rusia, Suiza, Turquía, Austria, Noruega, Hungría, Lituania, Irlanda, Polonia y el resto de Europa.
Se espera que el segmento de radioinmunoensayo en la región de Europa crezca con la tasa de crecimiento más alta en el período de pronóstico de 2021 a 2028 debido a su alta especificidad y sensibilidad.
La sección de países del informe también proporciona factores de impacto individuales en el mercado y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, leyes regulatorias y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, se considera la presencia y disponibilidad de marcas europeas y los desafíos que enfrentan debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los canales de venta al proporcionar un análisis de pronóstico de los datos del país.
Las aprobaciones de productos y las novedades en los procedimientos de diagnóstico están impulsando el crecimiento del mercado de los contadores gamma de inmunoensayo.
El mercado de contadores gamma de inmunoensayo también le proporciona un análisis detallado del mercado para el crecimiento de cada país en la industria de la terapia con bacteriófagos con ventas de medicamentos, impacto del avance, tecnología y cambios en los escenarios regulatorios con su apoyo al mercado de medicamentos para el TOC. Los datos están disponibles para el período histórico de 2010 a 2019.
Análisis del panorama competitivo y de la cuota de mercado de la terapia con bacteriófagos
El panorama competitivo del mercado de contadores gamma de inmunoensayo proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y amplitud de los productos, el dominio de las aplicaciones y la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de contadores gamma de inmunoensayo.
Las principales empresas que operan en el mercado europeo de contadores gamma de inmunoensayo son Hidex Oy, Perkin Elmer Inc, Berthold Technologies GmbH & Co. KG, ENERSYS Co. Ltd, Shinjin Medics Inc, LabLogic Systems Ltd, entre otras.
Muchos lanzamientos de productos y acuerdos también son iniciados por empresas de todo el mundo que también están acelerando el mercado de contadores gamma de inmunoensayo.
Por ejemplo,
- En julio de 2021, PerkinElmer Inc. anunció que la empresa busca expandir aún más su presencia en la India recurriendo a productos innovadores. Los nuevos productos se lanzarán en diversas áreas, como la ciencia, la industria farmacéutica y las pruebas de alimentos. Esto ha ayudado a la empresa a expandir su presencia global.
- En noviembre de 2020, Berthold Technologies GmbH & CO.KG anunció que se había ordenado un confinamiento parcial para reducir la tasa de infección. Sin embargo, la empresa aseguró a los clientes que la entrega sería fiable, ya que seguirían produciendo durante este tiempo, siguiendo las directrices adecuadas del gobierno. Esto ayuda a la empresa a mantener la demanda y generar ingresos durante la pandemia.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias del actor del mercado están mejorando el mercado de la empresa en el mercado de contadores de inmunoensayo-gamma, lo que también brinda el beneficio para que la organización mejore su oferta de contadores de inmunoensayo-gamma.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE Immunoassay-gamma counters market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- product TYPE LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET APPLICATION COVERAGE GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- pestel analysis
- portes five forces
- REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS
- U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS
- EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
- JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
- CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
- Market Overview
- DRIVERS
- IncreASE IN Prevalence of chronic diseaseS
- PRODUCT APPROVAL
- IncreasE IN adoption of Nuclear Medicine
- Novelty in Diagnosis Procedures
- upgrading Gamma technology
- RESTRAINTS
- High Cost of gamma counter
- Risk of gamma radiation
- Stringent regulation of clinical use of gamma counter
- product recall
- Opportunities
- Growing Research and development expenditure
- IncreasE IN healthcare expenditure
- Rise in patients awareness towards chronic disease treatment
- CHALLENGES
- challenges in using gamma counter
- Lack of skilled and certified professionals
- IMPACT OF COVID-19 ON EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET
- IMPACT ON THE PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY
- STRATEGIC INITIATIVES BY MANUFACTURERS
- CONCLUSION
- Europe IMMUNOASSAY-GAMMA COUNTERS maRKET, BY PRODUCT TYPE
- overview
- AUTOMATED
- Radioimmunoassays
- RIA
- IRMA
- Nuclear Medicine Assays
- GFR (Glomerular FILTRATION RATE)
- Gamma glutamyl transferase (ggt)
- red cell mass and plasma volume test
- THE SCHILLING TEST
- others
- OTHERS
- MANUAL/SEMI-AUTOMATED
- Radioimmunoassays
- RIA
- IRMA
- Nuclear Medicine Assays
- GFR (Glomerular FILTRATION RATE)
- Gamma glutamyl transferase (ggt)
- red cell mass and plasma volume test
- THE SCHILLING TEST
- others
- OTHERS
- Europe immunoassay-gamma counters market, BY well
- overview
- MULTI-WELL
- SINGLE-WELL
- Europe immunoassay-gamma counters market, BY APPLICATION
- overview
- RADIO IMMUNOASSAYS
- RIA
- IRMA
- NUCLEAR MEDICINE ASSAY
- GFR (GLOMERULAR FILTRATION RATE)
- gamma-glutamyl transferase
- red cell mass and plasma volume test
- THE SCHILLING TEST
- others
- OTHERS
- Europe immunoassay-gamma counters market, BY DISEASE CONDITION
- overview
- cancer biomarkers
- CARBOHYDRATE ANTIGEN 125 (CA125)
- CARBOHYDRATE ANTIGEN 19-9
- caRCINO EMBRYONIC ANTIGEN
- alpha-fetoprotein
- others
- infectious diseases
- therapeutic drug monitoring
- endocrine hormones
- ALLERGY
- NEONATAL SCREENING
- cardiac markers
- autoimmune disease
- others
- Europe immunoassay-gamma counters market, BY purchase mode
- overview
- Outright purchase
- rental purchase
- Europe Immunoassay-gamma Counters Market, BY distribution channel
- overview
- DIRECT TENDER
- THIRD PARTY DISTRIBUTORS
- Europe Immunoassay-gamma Counters Market, BY end user
- overview
- HOSPITALS
- LABORATORY
- BLOOD BANKS
- RESEARCH AND ACADEMIC INSTITUTES
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- OTHERS
- EUROPE Immunoassay-Gamma Counters MARKET, by geography
- EUROPE
- GERMANY
- U.K.
- France
- ITALY
- SPAIN
- NETHERLANDS
- RUSSIA
- SWITZERLAND
- BELGIUM
- TURKEY
- REst of europe
- EUROPE Immunoassay-Gamma counters Market: COMPANY landscape
- company share analysis: Europe
- swot analysis
- company profile
- perkinelmer inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- Company Share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- bRETHOLD TECHNOLOGIES gMBH & CO.KG
- COMPANY SNAPSHOT
- Company Share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- LabLogic Systems Ltd.
- COMPANY SNAPSHOT
- Company Share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SHIN JIN MEDICS INC.
- COMPANY SNAPSHOT
- Company Share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- hidex oy
- COMPANY SNAPSHOT
- Company Share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- LABORATORY TECHNOLOGIES. inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- ENERSYS, Co.Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MIRION TECHNOLOGIES (CAPINTEC),INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Lista de Tablas
TABLE 1 Number of people with diabetes (Million) among ages 20–79 years
TABLE 2 Healthcare expenditure in asia-pacific
TABLE 3 Europe immunoassay-gamma counters market, By PRODUCT TYPE, 2015-2028 (USD Million)
TABLE 4 Europe AUTOMATED in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 5 Europe automated in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)
TABLE 6 Europe Radioimmunoassays in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)
TABLE 7 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)
TABLE 8 Europe manual/semi-automated in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 9 Europe manual/semi-automated in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)
TABLE 10 Europe radioimmunoassay in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)
TABLE 11 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 12 Europe immunoassay-gamma counters market, By WELL, 2015-2028 (USD Million)
TABLE 13 Europe multi-well in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 14 Europe single-well in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 15 Europe immunoassay-gamma counters market, By APPLICATION, 2015-2028 (USD Million)
TABLE 16 Europe RADIO IMMUNOASSAYS in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 17 Europe RADIO IMMUNOASSAYS in immunoassay-gamma counters market, By application, 2015-2028 (USD MILLION)
TABLE 18 Europe nuclear medicine assay in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 19 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By application, 2015-2028 (USD MILLION)
TABLE 20 Europe others in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 21 Europe immunoassay-gamma counters market, By disease condition, 2015-2028 (USD Million)
TABLE 22 Europe cancer biomarkers in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 23 Europe cancer biomarkers in immunoassay-gamma counters market, By disease condition, 2015-2028 (USD MILLION)
TABLE 24 Europe infectious diseases in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 25 Europe therapeutic drug monitoring in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 26 Europe endocrine hormones in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 27 Europe ALLERGY in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 28 Europe neonatal screening in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 29 Europe cardiac makers in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 30 Europe auto immune disease in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 31 Europe others in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 32 Europe immunoassay-gamma counters market, By purchase mode, 2015-2028 (USD Million)
TABLE 33 Europe Outright purchase in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 34 Europe rental purchase in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)
TABLE 35 Europe immunoassay-gamma counters Market, By distribution channel, 2015-2028 (USD million)
TABLE 36 Europe Direct Tender in Immunoassay-Gamma Counters Market, By Distribution Channel, 2015-2028 (USD million)
TABLE 37 Europe Third Party Distributors in Immunoassay-Gamma Counters Market, By Distribution Channel, 2015-2028 (USD million)
TABLE 38 Europe immunoassay-gamma counters Market, By end user, 2015-2028 (USD million)
TABLE 39 Europe Hospitals in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)
TABLE 40 Europe laboratory in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)
TABLE 41 Europe blood banks in Immunoassay-Gamma Counters Market, By End User, 20152028 (USD million)
TABLE 42 Europe research and academic institutes in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)
TABLE 43 Europe pharmaceutical and biotechnology companies in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)
TABLE 44 others in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)
TABLE 45 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By COUNTRY, 2015-2028 (USD Million)
TABLE 46 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 47 EUROPE AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 48 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 49 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 50 EUROPE MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 51 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 52 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 53 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 54 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 55 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 56 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 57 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 58 EUROPE Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 59 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 60 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 61 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 62 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 63 GERMANY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 64 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 65 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 66 GERMANY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 67 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 68 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 69 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 70 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 71 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 72 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 73 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 74 GERMANY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 75 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 76 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 77 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 78 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 79 U.K. AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 80 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 81 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 82 U.K. MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 83 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 84 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 85 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 86 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 87 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 88 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 89 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 90 U.K. Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 91 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 92 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 93 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 94 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 95 FRANCE AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 96 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 97 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 98 FRANCE MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 99 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 100 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 101 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 102 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 103 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 104 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 105 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 106 FRANCE Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 107 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 108 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 109 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 110 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 111 ITALY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 112 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 113 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 114 ITALY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 115 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 116 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 117 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 118 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 119 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 120 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 121 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 122 ITALY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 123 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 124 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 125 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 126 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 127 SPAIN AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 128 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 129 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 130 SPAIN MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 131 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 132 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 133 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 134 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 135 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 136 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 137 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 138 SPAIN Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 139 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 140 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 141 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 142 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 143 NETHERLANDS AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 144 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 145 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 146 NETHERLANDS MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 147 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 148 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 149 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 150 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 151 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 152 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 153 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 154 NETHERLANDS Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 155 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 156 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 157 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 158 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 159 RUSSIA AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 160 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 161 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 162 RUSSIA MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 163 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 164 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 165 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 166 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 167 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 168 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 169 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 170 RUSSIA Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 171 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 172 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 173 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 174 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 175 SWITZERLAND AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 176 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 177 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 178 SWITZERLAND MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 179 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 180 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 181 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 182 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 183 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 184 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 185 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 186 SWITZERLAND Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 187 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 188 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 189 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 190 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 191 BELGIUM AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 192 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 193 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 194 BELGIUM MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 195 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 196 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 197 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 198 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 199 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 200 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 201 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 202 BELGIUM Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 203 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 204 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 205 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 206 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
TABLE 207 TURKEY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 208 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 209 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 210 TURKEY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)
TABLE 211 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)
TABLE 212 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)
TABLE 213 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)
TABLE 214 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)
TABLE 215 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)
TABLE 216 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)
TABLE 217 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)
TABLE 218 TURKEY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)
TABLE 219 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)
TABLE 220 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)
TABLE 221 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)
TABLE 222 Rest of Europe IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)
Lista de figuras
FIGURE 1 Europe IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION
FIGURE 2 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION
FIGURE 3 Europe Immunoassay-gamma counters market: DROC ANALYSIS
FIGURE 4 Europe Immunoassay-gamma counters market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Immunoassay-gamma counters market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Immunoassay-gamma counters market: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Immunoassay-gamma counters market: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE Immunoassay-gamma counters market: APPLICATION COVERAGE GRID
FIGURE 10 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Europe Immunoassay-gamma counters market: SEGMENTATION
FIGURE 12 Increase in Prevalence of chronic diseaseS AND Growing use of Nuclear medicine is EXPECTED TO DRIVE THE Europe Immunoassay-gamma counters market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 AUTOMATED is expected to account for the largest share of the Europe IMMUNOASSAY-GAMMA COUNTERS MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF Europe immunoassay-gamma COUNTERS MARKET
FIGURE 15 Health Spending by Major Sources of Funds
FIGURE 16 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, 2020
FIGURE 17 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, 2021-2028 (USD Million)
FIGURE 18 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 Europe immunoassay-gamma counters market : BY WELL, 2020
FIGURE 21 Europe immunoassay-gamma counters market : BY WELL, 2021-2028 (USD Million)
FIGURE 22 Europe immunoassay-gamma counters market : BY WELL, CAGR (2021-2028)
FIGURE 23 Europe immunoassay-gamma counters market : BY WELL, LIFELINE CURVE
FIGURE 24 Europe immunoassay-gamma counters market : BY application, 2020
FIGURE 25 Europe immunoassay-gamma counters market : BY application, 2021-2028 (USD Million)
FIGURE 26 Europe immunoassay-gamma counters market : BY application, CAGR (2021-2028)
FIGURE 27 Europe immunoassay-gamma counters market : BY application, LIFELINE CURVE
FIGURE 28 Europe immunoassay-gamma counters market : BY disease condition, 2020
FIGURE 29 Europe immunoassay-gamma counters market: BY disease condition, 2021-2028 (USD Million)
FIGURE 30 Europe immunoassay-gamma counters market : BY disease condition, CAGR (2021-2028)
FIGURE 31 Europe immunoassay-gamma counters market : BY disease condition, LIFELINE CURVE
FIGURE 32 Europe immunoassay-gamma counters market : BY purchase mode, 2020
FIGURE 33 Europe immunoassay-gamma counters market : BY purchase mode, 2021-2028 (USD Million)
FIGURE 34 Europe immunoassay-gamma counters market : BY purchase mode, CAGR (2021-2028)
FIGURE 35 Europe immunoassay-gamma counters market : BY purchase mode, LIFELINE CURVE
FIGURE 36 Europe immunoassay-gamma counters market : BY distribution channel, 2020
FIGURE 37 Europe immunoassay-gamma counters market : BY distribution channel, 2021-2028 (USD Million)
FIGURE 38 Europe immunoassay-gamma counters market : BY distribution channel, CAGR (2021-2028)
FIGURE 39 Europe immunoassay-gamma counters market : BY distribution channel, LIFELINE CURVE
FIGURE 40 Europe immunoassay-gamma counters market : BY end user, 2020
FIGURE 41 Europe immunoassay-gamma counters market : BY end user, 2021-2028 (USD Million)
FIGURE 42 Europe immunoassay-gamma counters market : BY end user, CAGR (2021-2028)
FIGURE 43 Europe immunoassay-gamma counters market : BY end user, LIFELINE CURVE
FIGURE 44 EUROPE Immunoassay-gamma counters market : SNAPSHOT (2020)
FIGURE 45 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2020)
FIGURE 46 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2021 &2028)
FIGURE 47 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2020 & 2028)
FIGURE 48 EUROPE Immunoassay-gamma counters market : BY PRODUCT TYPE (2021-2028)
FIGURE 49 Europe Immunoassay-gamma counters market: company share 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
